DNA Ginkgo Bioworks
- 0.761
- -0.159-17.29%
- 0.759
- -0.002-0.30%
Ginkgo Bioworks News
Ginkgo Bioworks | S-3: Registration statement for specified transactions by certain issuers
Ginkgo Bioworks | 8-K: Ginkgo Bioworks Reports First Quarter 2024 Financial Results
Ginkgo Bioworks | DEF 14A: Definitive information statements
Ginkgo Bioworks | DEFA14A: Others
Ginkgo Bioworks | 8-K: Current report
Ginkgo Bioworks | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Ginkgo Bioworks | 8-K: Ginkgo Bioworks Reports Fourth Quarter and Full Year 2023 Financial Results
Ginkgo Bioworks | 8-K: Ginkgo Bioworks Provides Business Updates at J.P. Morgan Healthcare Conference
Ginkgo Bioworks | 8-K: Ginkgo Bioworks Reports Third Quarter 2023 Financial Results
Ginkgo Bioworks | 8-K: Current report
Ginkgo Bioworks | 8-K: Ginkgo Bioworks subsidiary Zymergen and some of its subsidiaries submit application for voluntary relief
Ginkgo Bioworks | 8-K: Ginkgo Bioworks and Google Cloud Partner to Build Next Generation AI Platform for Biological Engineering and Biosecurity
Ginkgo Bioworks | S-3: Registration statement for specified transactions by certain issuers
Ginkgo Bioworks | 8-K: UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
Ginkgo Bioworks | 8-K: Ginkgo Bioworks Reports Second Quarter 2023 Financial Results
Ginkgo Bioworks | 8-K: Poll Result of 2023 Annual Meeting of Shareholders
Ginkgo Bioworks | 8-K: Ginkgo Bioworks Reports First Quarter 2023 Financial Results
Ginkgo Bioworks | 8-K: Ginkgo Bioworks Announces Appointment of Steven P. Coen as Chief Accounting Officer
Ginkgo Bioworks | DEF 14A: Definitive proxy statements
Ginkgo Bioworks | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Analysis
Price Target
No Data
